Latest news

Insights

Top 10 High-Impact Careers Defining the Future of Life Sciences

Executive Summary The life sciences workforce in 2026 is being reshaped by AI integration, advanced therapeutics, regulatory complexity, and commercialization...
Clinical

In a late-stage trial, Intellia’s gene treatment for rare condition reduces swelling attacks

Intellia Therapeutics has announced that its experimental gene-editing drug reduced the number of swelling attacks in patients with a...
Clinical

Boehringer Reports Phase 3 Data on Survodutide Showing 16.6% Weight Loss at Week 76

Boehringer Ingelheim has reported results from a phase 3 clinical trial of its glucagon/GLP-1 dual agonist, survodutide, in adults...
Regulatory

Revolution Challenges Erasca’s ERAS-0015 Over Patent and Data Comparison Claims

Revolution Medicines has raised legal and competitive concerns against Erasca following recent developments in pancreatic cancer drug research. The...
Clinical

Novartis and PTC Advance Huntington’s Drug Votoplam to Phase 3 Following Mid-Stage Data

Novartis and PTC Therapeutics have moved their Huntington’s disease...
Commercial

Chiesi to Acquire KalVista for $1.9 Billion, Adding Oral HAE Therapy Ekterly

Italy-based Chiesi Group has agreed to acquire KalVista Pharmaceuticals...
Commercial

Teva Pens Deal Worth Over $700M to Buy Emalex

Teva Pharmaceuticals has agreed to acquire Emalex Biosciences in a deal valued at $700 million upfront, securing a late-stage...
Insights

Top 10 Pharma Companies Leading Innovation in Drug Development (2026)

Executive Summary Drug development in 2026 is undergoing a structural transformation driven by AI-enabled discovery, precision medicine, advanced biologics, and...
Uncategorized

Top 10 Emerging Trends in Life Sciences for 2026

Emerging Trends:Executive Summary The life sciences industry in 2026 is entering a phase of accelerated transformation, driven by the convergence...
Insights

Top 10 Breakthrough Therapies Shaping the Future of Medicine (2026)

Executive Summary The therapeutic landscape in 2026 is undergoing a...
Commercial

Lilly Continues Good M&A Run With $2.3B Deal For JAK Inhibitor Biotech Ajax

Eli Lilly continues its rapid pace of dealmaking, announcing...
Clinical

Oruka Therapeutics Reports Phase 2a Psoriasis Data Showing 63.5% Skin Clearance with ORKA-001

Oruka Therapeutics reported interim results from a phase 2a study of its experimental monoclonal antibody ORKA-001 in patients with...
Manufacturing

Avalyn Files for IPO Targeting Up to $209.7 Million to Advance Inhaled Lung Therapies

Avalyn Pharma, a Boston-based company focused on inhaled therapies for lung diseases, has outlined plans to advance a pipeline...
Clinical

TIGIT dream fails in phase three, Gilead breaks off its relationship with Arcus

The domvanalimab, an anti-TIGIT antibody from Gilead Sciences and Arcus Biosciences, is one of the most recent remaining anti-TIGIT...
Regulatory

Revolution Challenges Erasca’s ERAS-0015 Over Patent and Data Comparison Claims

Revolution Medicines has raised legal and competitive concerns against...
Editorial Team -
Commercial

Chiesi to Acquire KalVista for $1.9 Billion, Adding Oral HAE Therapy Ekterly

Italy-based Chiesi Group has agreed to acquire KalVista Pharmaceuticals...
Editorial Team -

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...
Editorial Team -

Regulatory

Regulatory

Revolution Challenges Erasca’s ERAS-0015 Over Patent and Data Comparison Claims

Revolution Medicines has raised legal and competitive concerns against...
Editorial Team -
Clinical

In a late-stage trial, Intellia’s gene treatment for rare condition reduces swelling attacks

Intellia Therapeutics has announced that its experimental gene-editing drug...
Clinical

Boehringer Reports Phase 3 Data on Survodutide Showing 16.6% Weight Loss at Week 76

Boehringer Ingelheim has reported results from a phase 3...
Regulatory

Revolution Challenges Erasca’s ERAS-0015 Over Patent and Data Comparison Claims

Revolution Medicines has raised legal and competitive concerns against...
Manufacturing

Lilly and Profluent Sign Up to $2.25 Billion Collaboration to Develop AI-Designed Genetic Medicines

Eli Lilly has entered into a multi-program research collaboration...

Research & Development

Market Access

Manufacturing

U.S. Biopharma Companies Advance Over $370B in Manufacturing and R&D Investments

Major drugmakers have announced more than $370 billion in...
Manufacturing

Novartis Plans 550 Layoffs in Switzerland While Expanding U.S. Manufacturing Footprint

 550 Layoffs ;Novartis has outlined several updates to its...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Top 10 High-Impact Careers Defining the Future of Life Sciences

Executive Summary The life sciences workforce in 2026 is being...
Editorial Team -
Manufacturing

Avalyn Files for IPO Targeting Up to $209.7 Million to Advance Inhaled Lung Therapies

Avalyn Pharma, a Boston-based company focused on inhaled therapies...
Editorial Team -